Losartan Potassium Tablets, 100 Mg Tablet
Product Images NDC 63629-2428

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 100 Mg (NDC 63629-2428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

A line graph comparing the percentage of patients with a primary endpoint over study months for Atenolol and Losartan Potassium. The graph shows cumulative percentages on the y-axis and study months on the x-axis, with a noted adjusted risk reduction of 13% and a p-value of 0.021.*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing the percentage of patients with fatal/non-fatal stroke over study months between Atenolol and Losartan Potassium. The graph shows adjusted risk reduction of 25% for Losartan Potassium compared to Atenolol with statistical significance (p=0.001).*

FDA Label Image

Figure 3 (Figure3)

A forest plot chart titled 'Primary Endpoint Events within Demographic Subgroups' comparing Losartan and Atenolol event rates. The chart displays hazard ratios with 95% confidence intervals for primary composite events and stroke (fatal/non-fatal) across various subgroups including age, gender, race, ISH, diabetes, and history of cardiovascular disease. Symbols indicate sample sizes, with hazard ratios visualized along a horizontal axis showing favoring either Losartan or Atenolol.*

FDA Label Image

Figure 4.jpg (Figure4)

A line graph comparing the percentage of patients experiencing an event over 48 months between losartan potassium and placebo groups. The graph includes a risk reduction value of 16.1% with a p-value of 0.022, indicating statistical data on losartan potassium's effects relative to placebo over time.*

FDA Label Image

Label (Lbl636292428)

Label for Losartan Potassium Tablets, USP 100 mg by Bryant Ranch Prepack. Features the NDC 63629-2428-1, a barcode, and the BRP Pharmaceuticals logo. The label indicates the prescription drug is supplied as 1000 tablets, with instructions about storage, child-resistant packaging, and manufacturer Jubilant Cadista Pharmaceuticals Inc.*

FDA Label Image

Losartan Potassium, Usp (Structure)

Chemical structure diagram of losartan potassium, illustrating the molecular arrangement of the active ingredient shown with labeled bonds, rings, and potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.